Due to the dependency of normal prostate (1) and prostate cancer (PCa) tissue (2) on androgen receptor signaling for development and proliferation, the main treatment for metastatic PCa is androgen deprivation therapy (ADT) (3). The gene discussed is AR; the disease is posterior cortical atrophy.